Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 July 2027
- Last conf. stmt
- 17 June 2026
Competitive Drug Development International Limited
- Incorporated
- 17 June 2009 (17 years)
- Previously known as
- Cddi Limited (until 23 March 2010)This list may be incomplete. See all names on Companies House
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Susan GoodmanEva Hurst
- Owned by
- Eva Hurst
- Accounts type
- Total exemption full
- Region
- South East
- Address
- Suite F2 Church House Business CentreChurch StreetGodalmingGU7 1EW
Officers 2 active
Officer details are public data from the Companies House register.
Goodman, Susan
Director · Appointed 14 April 2025
British
Born March 1963 (63)
Hurst, Eva
Director · Appointed 16 October 2016
Swiss
Born September 1969 (57)
Officer history (5 former)
14 April 2025
Appointed Goodman, Susan as Director
11 October 2024
Resigned Brown, Grahaem, Dr. as Director
16 October 2016
Appointed Hurst, Eva as Director
28 February 2015
11 November 2011
Resigned Tansey, Michael James Byron as Director
6 January 2011
11 January 2010
Resigned Salla, Gyongyi as Secretary
22 September 2009
Resigned Roman, Elizabeth Charlotte as Director
31 July 2009
Appointed Roman, Elizabeth Charlotte as Director
9 July 2009
Appointed Salla, Gyongyi as Secretary
22 June 2009
Appointed Brown, Grahaem, Dr. as Director
17 June 2009
Appointed Tansey, Michael James Byron as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Eva Hurst
Individual · Notified 19 October 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Swiss
Born September 1969 (57)
Former controllers (1)
11 October 2024
Ceased Grahaem Brown — Owns 25–50% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £117,974
- Employees
- 1
- Current Ratio
- 3.4x
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £670 | £1,714 | £1,783 | £1,739 | £1,634 | £3,953 |
| Current Assets | £167,767 | £186,293 | £446,248 | £307,569 | £244,620 | £361,309 |
| Debtors | £49,793 | £47,918 | £95,112 | £127,544 | £116,253 | £16,376 |
| Cash | £117,974 | £138,375 | £351,136 | £180,025 | £128,367 | £344,933 |
| Creditors (< 1 year) | £48,892 | £38,859 | £197,902 | £137,655 | £41,374 | £127,526 |
| Net Current Assets | £118,875 | £147,434 | £248,346 | £169,914 | £203,246 | £233,783 |
| Shareholder Funds | £119,545 | £149,148 | £250,129 | £171,653 | £204,880 | £237,736 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 25 August 2026 | Total exemption full accounts | 31 December 2025 | ||
| 11 August 2026 | Director's details changed | |||
| 11 August 2026 | Registered office address changed | |||
| 11 August 2026 | Director's details changed | |||
| 11 August 2026 | Change of details for a person with significant control |
Some other companies at this address
Other companies in this industry
Uxbridge
Weybridge
London
Birmingham
Reading
Stanmore
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →